Combination comprising a BCR [inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-N-[4methyl3-(4-pyridin-3-yl)pyrimidin-2-ylamino)ph enyl]-benzamide

Details for Australian Patent Application No. 2005269052 (hide)

Owner The Netherlands Cancer Institute

Inventors Schellens, Johannes Henricus Matthias; Van Tellingen, Olaf; Breedveld, Pauline; Pluim, Dick; Cipriani, Greta; Wielinga, Pieter Roeland

Agent Davies Collison Cave

Pub. Number AU-A-2005269052

PCT Pub. Number WO2006/012958

Priority 60/584,825 01.07.04 US

Filing date 30 June 2005

Wipo publication date 9 February 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2006/012958 Priority application(s): WO2006/012958

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269054-Hinged lid box for cigarettes and method and device for the production thereof

2005269044-Weather-stable titanium dioxide pigment and method for the production thereof